| Serial Number | 90318022 |
| Word Mark | OEP PHARMA |
| Filing Date | Friday, November 13, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, September 12, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, June 15, 2021 |
| Description of Mark | The mark consists of the stylized words "OEP Pharma" to the right of a miscellaneous design having an overall diamond shape. |
| Goods and Services | Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Pharmaceutical products for the prevention and treatment of cancer; Therapeutic pharmaceuticals for the treatment of cancer, cardiovascular diseases, metabolic diseases, musculoskeletal diseases, infectious diseases, and neurodegenerative diseases; Pharmaceutical preparations for the treatment of hyperlipidemia; Local anesthetics; Drug delivery agents in the form of a coating for tablets and capsules that facilitate the delivery of a wide range of pharmaceuticals; Medicinal preparations of the treatment of infectious diseases and for use in oncology; Anesthetics; Anesthetics for surgical purposes; Pharmaceutical preparations for treating diabetes; Anti-diabetic pharmaceuticals; Cardiovascular agents for medical purposes; Drug delivery agents in the form of transdermal patches, coatings for tablets, and synthetic materials that facilitate the delivery of pharmaceutical preparations; Skeletal muscle relaxants; Pharmaceutical preparations for treating hypertension; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations for the treatment of cancer, cardiovascular diseases, metabolic diseases, musculoskeletal diseases, infectious diseases, and neurodegenerative diseases; Anesthetics for surgical and non-surgical use; Pharmaceuticals, namely, lipid lowering agents; Pharmaceutical preparations for use in chemotherapy; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; Transdermal patches for use in the treatment of neurodegenerative disease; Cardiovascular pharmaceuticals; Hypolipidemic agents; Anesthetics for surgical use; Pain relief medication; Pharmaceutical products for the treatment of cancer; Hypolipidemic agents |
| Disclaimer with Predetermined Text | "PHARMA" |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, January 13, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Orient Europharma Co., Ltd. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Taipei TW |
| Party Name | Orient Europharma Co., Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Taipei TW |
| Event Date | Event Description |
| Monday, September 12, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, September 12, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, February 1, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, January 28, 2022 | SOU EXTENSION 1 GRANTED |
| Friday, January 28, 2022 | SOU EXTENSION 1 FILED |
| Friday, January 28, 2022 | TEAS EXTENSION RECEIVED |
| Tuesday, August 10, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, June 15, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, June 15, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 26, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, May 10, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, May 10, 2021 | EXAMINER'S AMENDMENT ENTERED |
| Monday, May 10, 2021 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, May 10, 2021 | EXAMINERS AMENDMENT E-MAILED |
| Monday, May 10, 2021 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, May 3, 2021 | NOTIFICATION OF PRIORITY ACTION E-MAILED |
| Monday, May 3, 2021 | PRIORITY ACTION E-MAILED |
| Monday, May 3, 2021 | PRIORITY ACTION WRITTEN |
| Friday, April 23, 2021 | ASSIGNED TO EXAMINER |
| Thursday, January 14, 2021 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, January 13, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, November 17, 2020 | NEW APPLICATION ENTERED IN TRAM |